Advanced search
Publication Cover
mAbs Volume 12, 2020 - Issue 1
Submit an article Journal homepage
2,730
Views
8
CrossRef citations to date
0
Altmetric
Report

Discovery and characterization of a neutralizing pan-ELR+CXC chemokine monoclonal antibody

Jeffrey S. Boylesa Biotechnology Discovery Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USAORCID Iconhttps://orcid.org/0000-0002-0546-3472
ORCID Icon,
Catherine B. Beidlerb Lilly Biotechnology Center, Lilly Research Laboratories, Eli Lilly and Company, San Diego, CA, USA
,
Beth A. Striflera Biotechnology Discovery Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA
,
Daniel S. Girardb Lilly Biotechnology Center, Lilly Research Laboratories, Eli Lilly and Company, San Diego, CA, USA
,
Zhanna Druzinac Discovery Chemistry Research Technologies, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA
,
Jim D. Durbinc Discovery Chemistry Research Technologies, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USAORCID Iconhttps://orcid.org/0000-0001-8691-0352
ORCID Icon,
Michelle L. Swearingend Oncology Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA
,
Linda N. Leed Oncology Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA
,
Kristine Kiklye Immunology Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA
,
Sudhakar Chintharlapallid Oncology Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USAORCID Iconhttps://orcid.org/0000-0001-7848-1674
ORCID Icon &
Derrick R. Witchera Biotechnology Discovery Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2248-0143
ORCID Icon show all
Article: 1831880 | Received 22 May 2020, Accepted 16 Sep 2020, Published online: 13 Nov 2020

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

T.T.N. Tran, Q.H. Tran, Q.T. Nguyen, M.T. Le, D.T.T. Trinh, V.H. Tran & K.M. Thai. (2022) LY3041658/ interleukin-8 complex structure as targets for IL-8 small molecule inhibitors discovery using a combination of in silico methods. SAR and QSAR in Environmental Research 33:10, pages 753-778.
Read now

Articles from other publishers (7)

Lin Cheng, Fan Xia, Ziyan Li, Chenglong Shen, Zhiqian Yang, Hanlin Hou, Suyue Sun, Yuying Feng, Xihao Yong, Xiaowen Tian, Hongxi Qin, Wei Yan & Zhenhua Shao. (2023) Structure, function and drug discovery of GPCR signaling. Molecular Biomedicine 4:1.
Crossref
Beata Marciniak, Mateusz Kciuk, Somdutt Mujwar, Rajamanikandan Sundaraj, Karol Bukowski & Renata Gruszka. (2023) In Vitro and In Silico Investigation of BCI Anticancer Properties and Its Potential for Chemotherapy-Combined Treatments. Cancers 15:18, pages 4442.
Crossref
Natalie M. Fragoso, Rahul Masson, T. Justin Gillenwater, Vivian Y. Shi & Jennifer L. Hsiao. (2023) Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies. Dermatology and Therapy 13:8, pages 1661-1697.
Crossref
Klara Hellauer, Olga V. Oskolkova, Bernd Gesslbauer & Valery Bochkov. (2023) Pharmacological heat-shock protein inducers and chemical chaperones inhibit upregulation of interleukin-8 by oxidized phospholipids. Inflammopharmacology 31:3, pages 1319-1327.
Crossref
Dongqi Xing, Fadi G. Hage, Wenguang Feng, Yuanyuan Guo, Suzanne Oparil & Paul W. Sanders. (2023) Endothelial cells overexpressing CXCR1/2 are renoprotective in rats with acute kidney injury. American Journal of Physiology-Renal Physiology 324:4, pages F374-F386.
Crossref
Yulan Mo, Leanne L. Leung, Celia S. L. Mak, Xueyu Wang, Wai-Sun Chan, Lynn M. N. Hui, Hermit W. M. Tang, Michelle K. Y. Siu, Rakesh Sharma, Dakang Xu, Stephen K. W. Tsui, Hextan Y. S. Ngan, Mingo M. H. Yung, Karen K. L. Chan & David W. Chan. (2023) Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis. Molecular Cancer 22:1.
Crossref
Siyuan Song, Jiayu Zhou, Ye Li, Jiatong Liu, Jingzhan Li & Peng Shu. (2022) Network pharmacology and experimental verification based research into the effect and mechanism of Aucklandiae Radix–Amomi Fructus against gastric cancer. Scientific Reports 12:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.